4//SEC Filing
Fedeli Fabiana 4
Accession 0001213900-24-047635
CIK 0001553643other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 9:24 PM ET
Size
8.5 KB
Accession
0001213900-24-047635
Insider Transaction Report
Form 4
Fedeli Fabiana
Director
Transactions
- Award
Stock Option (right to buy)
2024-05-24+20,976→ 52,498 totalExercise: $2.48From: 2024-03-15Exp: 2033-12-15→ Common Stock (20,976 underlying) - Other
Stock Option (right to buy)
2024-05-24−20,976→ 31,522 totalExercise: $2.48From: 2024-03-15Exp: 2033-12-15→ Common Stock (20,976 underlying)
Footnotes (2)
- [F1]On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 20,976 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares.
- [F2]On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001961902
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 9:24 PM ET
- Size
- 8.5 KB